TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
6.68
+0.62 (10.23%)
At close: Dec 6, 2024, 4:00 PM
6.69
+0.01 (0.15%)
After-hours: Dec 6, 2024, 7:58 PM EST

TuHURA Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022
Period Ending
Sep '24 Dec '23 Dec '22
Selling, General & Admin
3.354.142.01
Research & Development
11.279.47.93
Operating Expenses
14.6113.559.93
Operating Income
-14.61-13.55-9.93
Interest Expense
-3.63-0.02-
Interest & Investment Income
0.210.090.06
Other Non Operating Income (Expenses)
-0.310.040.21
EBT Excluding Unusual Items
-18.35-13.43-9.66
Other Unusual Items
-0.330.29
Pretax Income
-18.37-29.32-9.37
Net Income
-18.37-29.32-9.37
Net Income to Common
-19.33-29.32-9.37
Shares Outstanding (Basic)
7668-
Shares Outstanding (Diluted)
7668-
EPS (Basic)
-0.25-0.43-
EPS (Diluted)
-0.25-0.43-
Free Cash Flow
-15.24-13.25-7.54
Free Cash Flow Per Share
-0.20-0.19-
EBITDA
-14.48-13.37-9.56
D&A For EBITDA
0.140.180.37
EBIT
-14.61-13.55-9.93
Source: S&P Capital IQ. Standard template. Financial Sources.